BioCentury
ARTICLE | Company News

Acambis, Bavarian Nordic infectious news

May 29, 2006 7:00 AM UTC

ACM said it filed an opposition to BAVA's European Patent No. 1,335,987 covering BAVA's MVA-BN Modified Vaccinia Ankara (MVA) technology. ACM said that partner Baxter Healthcare Corp. (BAX, Deerfield, Ill.), which manufactures ACM's MVA3000 MVA vaccine, also filed an opposition to the patent. ...